Protective actions of a luminally acting 5-HT 4 receptor agonist in mouse models of colitis.
Molly HurdMelody M HaagMatthew J KwasnikJill WykoskyBrigitte LavoieGary M MawePublished in: Neurogastroenterology and motility (2023)
R agonists may be useful as an adjuvant to current inflammatory bowel disease (IBD) treatments to enhance epithelial healing.
Keyphrases